2005–2015 global analysis of advanced breast cancer

2005–2015 global analysis of advanced breast cancer

EMJ

3 years
517 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Fatima Cardoso, MD, from the Champalimaud Clinical Center, Lisbon, Portugal, discusses the collaboration between the European School of Oncology and Pfizer in the development of the Global Status of MBC: A Decade Report, an analysis of the global metastatic breast cancer landscape from 20052015. Despite showing areas of improvement, unmet needs were identified in patients with metastatic breast cancer, including the need for improved disease awareness, research and patient support. European Medical Journal Website: http://emjreviews.com/ Twitter: https://twitter.com/EMJReviews Facebook: https://www.facebook.com/emjreviews
Up Next Autoplay
Translating genomics to precision medicine for breast cancer care: Ongoing clinical studies
Translating genomics to precision medicine for breast cancer care: Ongoing clinical studies
Category: Acute Lymphoblastic Leukemia
869 Views
EMJ 3 years
Translating genomics to precision medicine for breast cancer care: Ongoing clinical studies
Translating genomics to precision medicine for breast cancer care: Ongoing clinical studies
Category: Acute Lymphoblastic Leukemia
2 Views
EMJ 3 years
Translating genomics to precision medicine for breast cancer care: Ongoing clinical studies
Translating genomics to precision medicine for breast cancer care: Ongoing clinical studies
Category: Acute Lymphoblastic Leukemia
6 Views
EMJ 3 years
Identifying breast cancer patients who can be spared chemotherapy, evidence from recent studies
Identifying breast cancer patients who can be spared chemotherapy, evidence from recent studies
Category: Acute Lymphoblastic Leukemia
595 Views
EMJ 3 years
Impact of phase 3 PlanB trial on evidence-based breast cancer management in clinical practice
Impact of phase 3 PlanB trial on evidence-based breast cancer management in clinical practice
Category: Acute Lymphoblastic Leukemia
933 Views
EMJ 3 years
5-year outcomes from PlanB: Phase 3 trial evaluating the Oncotype DX® Breast Cancer Assay in node-positive and high-risk node-negative breast cancer
5-year outcomes from PlanB: Phase 3 trial evaluating the Oncotype DX® Breast Cancer Assay in node-positive and high-risk node-negative breast cancer
Category: Acute Lymphoblastic Leukemia
539 Views
EMJ 3 years
Overview of prospective phase 3 PlanB trial of 21-gene Recurrence Score® result in breast cancer
Overview of prospective phase 3 PlanB trial of 21-gene Recurrence Score® result in breast cancer
Category: Acute Lymphoblastic Leukemia
594 Views
EMJ 3 years
Addressing inequalities and unmet needs in breast cancer patients
Addressing inequalities and unmet needs in breast cancer patients
Category: Acute Lymphoblastic Leukemia
500 Views
EMJ 3 years
Breast cancer in Europe: Epidemiology and improving outcomes
Breast cancer in Europe: Epidemiology and improving outcomes
Category: Acute Lymphoblastic Leukemia
431 Views
EMJ 3 years